Click on image to view larger version.

Figure 3 Delay in clinical worsening in bosentan-treated patients. Clinical worsening was defined as death, premature withdrawal from study, hospitalization for worsening pulmonary arterial hypertension, or initiation of epoprostenol. (From Rubin et al. [28]).